14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state
Abstract Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson’s disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we pres...
Saved in:
| Main Authors: | Juliana A. Martinez Fiesco, Alexandra Beilina, Astrid Alvarez de la Cruz, Ning Li, Riley D. Metcalfe, Mark R. Cookson, Ping Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-62337-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosome
by: Michael T. Maloney, et al.
Published: (2025-08-01) -
Models for LRRK2-Linked Parkinsonism
by: Tianxia Li, et al.
Published: (2011-01-01) -
The Multifaceted Role of LRRK2 in Parkinson’s Disease
by: Dong Hwan Ho, et al.
Published: (2025-04-01) -
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism
by: Bernd K Gilsbach, et al.
Published: (2024-12-01) -
LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain
by: Sitki Cem Parlar, et al.
Published: (2025-04-01)